Olympus Announces Support for CMS Rule Change to Eliminate Cost Sharing for Preventive Colorectal Cancer Screenings – QNT Press Release

[ad_1]

Decision by the Centers for Medicare and Medicaid Services lowers barriers to healthcare access for individuals with Medicare

CENTER VALLEY, Pa., Nov. 14, 2022 /PRNewswire/ — Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, today applauded the decision by the Centers for Medicare and Medicaid Services (CMS) to eliminate cost sharing for Medicare beneficiaries who have a colonoscopy in follow-up to a positive at-home colorectal cancer test. Prior to this policy change by CMS, patients whose at-home screen resulted in concerning results were faced with co-pay costs associated with follow-up colonoscopy; these costs are now eliminated for the covered patient. Olympus also supports the decision for Medicare to cover colonoscopies beginning at age 45, which is in line with the new age recommendation from the United States Preventive Services Task Force (USPSTF).1

“These rule changes represent a significant step toward improving colorectal cancer care and expanding access to preventive screenings,” said Paul Skodnyexecutive director, Global Health Economics & Market Access at Olympus Corporation of America. “The…

Full story available on Benzinga.com

[ad_2]

Source link

Recommended For You

About the Author: News Center